DELSOL Avocats is proud to be ranked in 11 Legal 500 EMEA 2026 categories : M&A : Smaller deals – Tier 1 The regions – Tier 1 Industry focus : Healthcare and life sciences – Tier 2 Construction – Tier 3 Data privacy and data protection – Tier 3 Private equity : venture/growth capital – Tier 3 Dispute resolution : Commercial litigation – Tier 4...
ReadAreas of expertise
Aura practices in the following main areas :
- Advice to healthcare companies on regulatory matters (healthcare products, relationship between healthcare industries and healthcare professionals …)
- Personal data protection
- Drafting and amending of agreements
Professional practice
Aura is a lawyer, admitted to the Paris Bar. Aura joined DELSOL Avocats in 2021 after other experiences in lawyer practices specialized in healthcare law.
Aura has been designated as a Leading associate in Healthcare & life sciences by Legal 500 in 2026.
Education
- CAPA (2017),
- Master II Droit de l’industrie de la santé (Université Paris V Descartes - 2014)
Languages
French, English
- 2026-03-25
- Mathieu LE TACON, Jeanne BOSSI MALAFOSSE, Gaëlle MERLIER, Geoffroy GOUBIN, Hélène LABORDE, Aura BRAUN
- Mergers & Acquisitions - Corporate law, Employment law - Social welfare law, Wealth law & taxation, Corporate taxation, Civil and commercial litigation, White-Collar crime - Compliance, Real estate - Construction, Life sciences, Personal data
- 2025-07-22
- Jeanne BOSSI MALAFOSSE, Aura BRAUN,
- Personal data, Life sciences
DELSOL Avocats has advised the AGORiA Santé consortium, in partnership with BIOGROUP, on obtaining the CNIL’s (French data protection authoritys) first authorization to combine biology and SNDS (French national health data system) data in a health data warehouse. Created in 2021, the AGORIA Santé consortium comprises AstraZeneca France, Takeda...
Read- 2025-06-20
- Jeanne BOSSI MALAFOSSE, Gaëlle MERLIER, Aura BRAUN, Camille NICOLAÏ,
The Draft Economic Life Simplification Bill, passed by the French National Assembly on June 17th, 2025, seeks to promote French innovation in the healthcare sector by easing both the practical conditions for conducting researches in France and the administrative formalities that accompany it. Indeed, the very name of the title - “Simplify to...
Read
